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Abstract
Background: Changes in DNA methylation patterns with age frequently have been observed and implicated in
the normal aging process and its associated increasing risk of disease, particularly cancer. Additionally, the offspring
of older parents are at significantly increased risk of cancer, diabetes, and neurodevelopmental disorders. Only a
proportion of these increased risks among the children of older parents can be attributed to nondisjunction and
chromosomal rearrangements.
Results: Using a genome-wide survey of 27,578 CpG dinucleotides in a cohort of 168 newborns, we examined the
relationship between DNA methylation in newborns and a variety of parental and newborn traits. We found that
methylation levels of 144 CpGs belonging to 142 genes were significantly correlated with maternal age. A weaker
correlation was observed with paternal age. Among these genes, processes related to cancer were over-
represented, as were functions related to neurological regulation, glucose/carbohydrate metabolism,
nucleocytoplasmic transport, and transcriptional regulation. CpGs exhibiting gender differences in methylation were
overwhelmingly located on the X chromosome, although a small subset of autosomal CpGs were found in genes
previously shown to exhibit gender-specific differences in methylation levels.
Conclusions: These results indicate that there are differences in CpG methylation levels at birth that are related to
parental age and that could influence disease risk in childhood and throughout life.
Background
DNA methylation is a normal, heritable epigenetic mod-
ification that down-regulates the expression of approxi-
mately 1/3 of human genes [1-3] and is key to the
allele-specific imprinting of genes [4]. DNA methylation
also plays an important role in disease. For example,
overall DNA hypomethylation accompanied by gene-
specific hypermethylation is a hallmark of cancer [5].
Additionally, shifts in DNA methylation patterns appear
to be involved in the normal aging process and increase
in disease susceptibility [6]. Indeed, there is ample evi-
dence for characteristic changes in the patterns of DNA
methylation with age.
The earliest data supporting progressive changes in
DNA methylation patterns with age came from global
studies of blood that demonstrated lower levels of
methylation in older individuals [7] and greater
differences in methylation in older monozygotic twins
[8]. Christensen et al. [9] examined 217 tissues sampled
from a range of non-diseased solid tissues and blood. In
solid tissues the general trend was towards methylation
increasing with age in CpG islands and decreasing out-
side of islands. However, in 85 blood samples the predo-
minant pattern was a decrease in DNA methylation with
age that was independent of CpG island status. In an
analysis of 280 CpGs measured from whole blood from
46 monozygotic and dizygotic twin pairs and 96 single-
ton adults, Boks et al. [10] found both increases (60%)
and decreases in methylation with age among the 100
most significant results. As previously observed, levels of
methylation for X-linked loci were higher among
females. Heritability estimates for methylation levels for
25 significant (p ≤ 10-3) CpGs ranged from 0.57 - 0.94.
Similarly, in whole blood samples from 93 females using
Illumina’s Humanmethylation27 BeadChip (the same
microarray as used in this study) Rakyan et al. [11]
found 213 CpGs whose methylation levels positively cor-
related with age ("hyper-aDMRs”) and 147 that
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negatively correlated. In a replication cohort of 20
females and 5 males, 60% (131) of CpGs whose methyla-
tion increased with age replicated in CD14+ monocytes
and CD4+ T-cells, while the CpGs whose methylation
decreased replicated in the T-cells but not monocytes.
Rakyan et al. suggested that the lack of replication in the
monocytes was due to changes in cell composition in
blood with age. Only the hyper-aDMRs were studied in
buccal cells from ten individuals, where they showed
high replication. A larger study [12] (N = 197, 21 - 55
years old) of DNA isolated from the saliva of alcohol abu-
sers using the same Illumina array as the one reported
here found 85 CpGs significantly correlated (including 29
negatively) with age after Bonferroni correction. In
another study using the same array for blood from 261
postmenopausal women, Teschendorff et al. [13] found
significant hypermethylation of 226 CpGs and hypo-
methylation of 363 CpGs with age. Replication results
were not presented for all significant CpGs, but focusing
on only those mapped to polycomb group proteins the
64 genes with hypermethylated sites replicated in other
tissues and individuals, while the 11 hypomethylated
genes generally did not. Once again, this could be due to
changes in blood cell composition with age.
The studies summarized above investigated the rela-
tionship between age and DNA methylation levels in a
cross-sectional sample of individuals at a fixed point in
time. Studies that have examined changes in DNA
methylation levels in the same individuals over time
have revealed similar results. Bollati et al. [14] studied
levels of DNA methylation in Alu and LINE-1 repetitive
elements in serial blood samples taken up to eight years
apart from 718 elderly Boston individuals (55 - 92 years
old). They found a significant correlation between age
and DNA methylation in both types of elements and
significant declines in methylation in Alu elements in
the same individual over time. Similarly, Bjornsson et al.
[15] studied changes in DNA methylation in blood in
the same individuals over a span of greater than
10 years. Although results were not presented for all
families or as summaries across all families, the 50 lar-
gest changes in blood mostly appeared to be decreases
both inside and outside of CpG islands. After excluding
one family that exhibited unusually consistent changes
in DNA methylation over time, Bjornsson et al. esti-
mated a heritability for DNA methylation change over
time of 0.743.
There is typically a very high correlation between the
ages and social/environmental exposures of parents that
makes it difficult to disentangle the relative roles of
maternal and paternal ages in adverse outcomes in their
offspring. Generally, very large epidemiological studies
are required that include a statistically meaningful sub-
set of parents with discordances in age. Based on such
studies, both maternal and paternal age correlate with
elevated risks of complications during pregnancy and
complex disorders in the offspring, such as intrauterine
growth retardation, altered placental morphology, pree-
clampsia, and preterm labor [16]. Although the connec-
tion is controversial in some cases, the offspring of
older parents have increased risks of various disorders,
such as type 1 diabetes [17], obsessive-compulsive disor-
ders, autism [18], schizophrenia [19], bipolar disorder
[20], stuttering [21], hematologic cancers [22], and the
more common childhood cancers [23-29]. Furthermore,
daughters of older women have an increased risk of
breast cancer [30], and the sons of older fathers have an
increased risk of prostate cancer [31]. The role of epige-
netics in these associations is only beginning to be
explored. The only recent recognition of a possibly large
role of epigenetics may be partially attributed to
assumptions that each generation begins with a
“renewed” epigenome. After fertilization the maternal
and paternal genomes undergo a rapid demethylation of
most of the genome followed by remethylation. Naively,
this suggests that each generation begins with a
refreshed epigenome that, barring gross environmental
insults or altered dietary intakes [32], is relatively
immune to effects from the previous generation [33,34].
Here we report the results of genome-wide DNA methy-
lation profiling of 168 newborns that indicates that there
is a general trend towards hypomethylation of CpG
islands in newborn blood cells with increasing parental
age. It is possible that this trend provides a partial
explanation for the association between increased paren-
tal age and adverse outcomes in offspring.
Results
Final characteristics of the data set and population
Across all 168 newborns, two CpGs exceeded a median
detection p value of 10-6 and were excluded from analy-
sis. The final data set was comprised of 27,576 CpG
dinucleotides. An average of 184 ± 498 (range 0 - 2,989)
CpGs per newborn exceeded the threshold detection p
value of ≤ 10-3, and those specific CpGs within indivi-
dual newborns were dropped from analyses.
The distribution of maternal ages was skewed towards
younger mothers, with 41% (N = 69) being younger
than 26 and the proportion diminishing with increasing
age (Table 1; 26-30 yrs, 33%, N = 55; 31-35 yrs, 20%,
N = 34; 36-39 yrs, 6%, N = 10). Most mothers were
classified as normal weight or overweight at the time of
recruitment according to body mass index (BMI), with
5.4% (N = 9) mothers being underweight (BMI < 18.5),
46% (N = 77) normal (BMI = 18.5 - 24.9), 20% (N = 34)
overweight (BMI = 25 - 29.9), and 29% (N = 48) obese
(BMI > 29.9). The majority of newborns were born at
term (≥ 37 weeks; N = 158), while seven were near-term
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(35 - 36 weeks) and three were preterm (32 - 33 weeks).
Birth weights ranged from 1.2 to 5 Kg, with the lower
end of the range primarily due to the small number of
preterm newborns. There were slightly more male (N =
88, 52%) than female newborns. There was no difference
in the average age of mothers giving birth to female or
male newborns (t test, p = 0.91). The age was reported
for 89 fathers, which averaged 31.6 years. Unlike the
maternal ages, the distribution of paternal ages was nor-
mally distributed (Shapiro-Wilk W test, p = 0.74; 18
- 25 years, 20%, N = 18; 26 - 30 years, 21%, N = 19; 31
- 35 years, 29%, N = 26; 36 - 40 years; 21%, N = 19; 41
- 50 years, 8%, N = 7).
Relationship between newborn CpG methylation levels
and maternal/newborn variables
No CpG displayed a significant relationship between
methylation level and gestational age, parity, maternal
BMI, birth weight, or to self-declared smoking during
pregnancy. Across all chromosomes, the levels of methy-
lation at 144 CpG loci located in 140 autosomal (2 each
in ARFGAP3 and MEA1) and 2 X-linked genes exhibited
genome-wide significant correlations with maternal age
(Additional File 1, Table S1). Relative to other loci,
imprinted genes generally maintain a stringent pattern
of allele-specific methylation in a parent of origin man-
ner. Nevertheless, a single CpG in each of two imprinted
genes (KCNQ1 and DIRAS3) were the third- and eigh-
teen-ranked sites (rho = -0.41 and -0.40, respectively)
correlated with maternal age. The level of methylation
at all but 9 of the 144 genome-wide significant CpGs
was negatively correlated with maternal age. With the
exception of six genes, at least two CpGs are interro-
gated in each of the 142 genes containing genome-wide
significant CpG probes. To determine if the pattern we
observe for the genome-wide significant CpGs is
reflected by another CpG in the same gene, we exam-
ined the direction and significance of the Spearman rho
for the CpG with the next lowest p value. Of the 136
genes represented by multiple probes, 95 of the second-
ranked CpGs exhibited a correlation in the same
direction as the top-ranked CpG, of which 53 were sig-
nificant at a nominal p value ≤ 0.05 (Additional File 2,
Table S2). The levels of methylation of these 53 pairs of
CpGs are significantly correlated (Spearman’s rho =
0.26 - 0.82, p = 6.3 × 10-4 - 2.1 × 10-42), except the pair
in the GORASP1 gene (rho = 0.07, p = 0.39).
Of the 144 CpGs exhibiting a significant correlation
with maternal age, all but 8 (5.6%) are located in CpG
islands. By contrast, 7,568 (27.45%) of the CpGs in the
total data set are outside of a CpG island. If there were
no relationship between the CpG island status of each
probe and its correlation with maternal age, we would
expect 39-40 of the significantly correlated CpGs to be
outside of an island. Therefore, there is a significant
(binomial test, p = 1.6 × 10-11) over-representation of
CpG island sites among the significant correlations. Of
the nine significantly positive correlations between
maternal age and newborn CpG methylation, four are
outside of a CpG island. Indeed, overall there appears to
be a different relationship between maternal age and
levels of methylation of CpGs located inside and outside
of CpG islands (Figure 1). Outside of CpG islands, the
distribution of Spearman rho statistics is slightly shifted
towards positive correlations (median = 0.02), while
inside CpG islands the correlations are predominantly
negative (median = -0.1).
Of the 834 CpG loci (501 genes) whose methylation
levels are significantly associated with newborn gender,
Table 1 Characteristics of the participants (n = 168)




Other, Multiracial (N) 6
Mothers
Age (years) 27.0 (5.1) 18 - 39
Parity 1.1 (1.2) 0 - 5
BMI (Kg/m2) 27.0 (7.3) 15.3 - 54.9
Smoke during pregnancy (N) 15
Paternal age (N = 89) 31.6 (7.1) 18 - 50
Newborns
Gestational age (weeks) 39.0 (1.3) 32 - 41
Female (N) 80
Birth weight (Kg) 3.3 1.2 - 5.0
Figure 1 Distribution of the Spearman rank correlation rho
statistics between maternal age and newborn CpG
methylation. Using the annotation of the Humanmethylation27
array provided by Illumina Inc., the distribution of rho statistics was
plotted for CpG dinucleotides outside of CpG islands (left) and
inside islands (right).
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all but 16 (14 genes) are located on the X chromosome,
and these associations are presumably due to a systema-
tic difference between males and females in the average
level of DNA methylation on the X [35]. Six (C6orf68,
TLE1, GLUD1, NUPL1, FLJ20582, FLJ43276) of the
fourteen autosomal loci exhibiting gender-specific differ-
ences in methylation levels were also among the eleven
loci found to exhibit genome-wide significant gender
differences in adult saliva DNA based on the same Illu-
mina array in a study by Liu et al. [12]. Additionally,
and consistent with our observation, Philibert et al. [36]
demonstrated higher methylation of the SLC6A4 gene,
posited to be important in several psychiatric and beha-
vioral traits, in adult females. Combined, these results
indicate that these gender-specific differences in methy-
lation of a small number of autosomal genes are replic-
able, present in multiple tissues, and established by the
time of birth. Other than zona pellucida-binding protein
2 (ZPBP2), none of the 14 autosomal genes has an
obvious function related to gender. The gender differ-
ence in X chromosome methylation could confound the
ability to detect a relationship to maternal age in ana-
lyses that include both genders. When analyses were
restricted to individual genders, the DNA methylation
level of one X-linked probe (cg08800033 at CETN2) was
genome-wide significant in male newborns, and none
were significant in females. If a less stringent Bonferroni
cut-off (p = 4.6 × 10-5) is employed based on the 1,085
CpGs located on the X, then three X-linked loci
(cg08800033 at CETN2, cg14570389 at RAP2C, and
cg17880859 at RBBP7) in males and one (cg06350107 at
OTC) in females is significant. In light of these results
and the expected decrease in power to detect a trend in
single genders, it is possible that the levels of methyla-
tion of a small subset of X-linked CpGs exhibit a corre-
lation with maternal age in a gender-specific manner.
However, the support for this is weak, and we did not
further examine gender-specific patterns for X-linked
CpGs with respect to maternal age.
Replication of maternal age correlation by
pyrosequencing
For 92 newborn DNA samples, the correlation between
maternal age and DNA methylation was reassessed
using pyrosequencing for three CpGs. These CpGs were
chosen based on their different levels of methylation
and the correlation of the methylation levels with mater-
nal age. Those three sites and their levels of methylation
and correlation with maternal age based on Illumina
data were cg09118625 (47 - 82%, rho = -0.38,
p = -.0002), cg18984151 (10 - 25%, rho = -0.34, p =
0.001), and cg21576698 (3 - 23%, rho = -0.31, p =
0.003). Based on pyrosequencing, the correlations with
maternal age were replicated (cg09118625, rho = -0.27,
p = 0.009; cg18984151, rho = -0.28, p = 0.007;
cg21576698, rho = -0.42, p = 3.6 × 10-5). However,
while the inferred levels of methylation of cg18984151
from pyrosequencing (12 - 23%) were very similar to
and highly correlated with the values from the array
(rho = 0.75, p = 4.6 × 10-18), the correlations for the
other sites were strong but the inferred methylation
levels shifted downwards (cg09118625, 39 - 48%, rho =
0.73, p = 2.4 × 10-16; cg21576698, 0 - 1.4%, rho = 0.28,
p = 0.008). Altogether these results indicate that the
correlation between maternal age and newborn DNA
methylation is replicable, but that the absolute methyla-
tion values derived from the Humanmethylation27 array
for some sites may be biased indicators of the true
values and may overestimate the true level of inter-indi-
vidual variation in methylation levels.
Relative strength of the correlation of maternal vs.
paternal age with newborn CpG methylation
The ages of the mothers and fathers were highly corre-
lated in our sample (Figure 2; Spearman rho = 0.75, p =
2 × 10-17). As a consequence, it would be extremely dif-
ficult to distinguish between the effects of maternal and
paternal age. This is particularly the case given that
there are only 31 cases of an age difference ≥ 5 years
and 7 cases of an age difference ≥ 10 years, providing
little statistical power to examine these subsets as a
unique category. The relative strength of the relation-
ship between CpG methylation and parental ages can be
qualitatively assessed by examining the relative magni-
tude of the correlation between methylation levels and
the ages of the 89 mothers and fathers for which we
have the ages of both. With only 89 observations, the
power to achieve genome-wide significance is reduced.
For paternal age, there are 6 correlations with a p value
Figure 2 Scatterplot comparison of maternal and paternal ages
among 89 newborns for which the age of both parents was
known.
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≤ 10-4 (84 at p ≤ 10-3), while for maternal age there is
one CpG significant at the genome-wide level
(cg00231644 in TUBB2A, p = 1.54 × 10-6), 7 additional
CpGs with p ≤ 10-5, and a total of 106 with p ≤ 10-4.
Therefore, it appears that the relationship of newborn
CpG methylation with maternal age is stronger and
involves a larger number of sites than does that with
paternal age.
Role of Population Stratification or Sequence
Polymorphism
We have previously demonstrated extensive differences
in DNA methylation levels between African-Americans
and Caucasians [37]. Therefore, our observed correla-
tions between maternal age and newborn DNA methyla-
tion levels could be confounded by these racial
differences, particularly given that the African-American
mothers are generally younger than the Caucasian
mothers (p = 0.0001, Wilcoxon rank-sum test). Based
on plots of the first two principal components using
genome-wide single nucleotide polymorphism (SNP)
data from a subset of newborns (60 African-American,
71 Caucasian; Figure 3), two rather distinct clusters of
individuals defined by both principal components are
clear. One cluster is composed of 57 maternally-declared
African-American and 3 Caucasian newborns, and the
other contains 6 African-American and 65 Caucasian
newborns. As expected based on the significant differ-
ence in maternal ages between the two races, the first
genetic principal component is significantly correlated
with maternal age (rho = -0.28, p = 0.0001), reinforcing
the possibility for confounding of racial and maternal
age effects. However, within each of the two clusters,
the correlation between the first principal component
and maternal age was not significant (p > 0.2), suggest-
ing that analyses within these clusters of modest genetic
homogeneity would be much less subject to confound-
ing of racial, genetic, and maternal age effects.
Within each cluster defined by genetic principal com-
ponents, correlation analysis was performed between
maternal age and DNA methylation at each CpG. Given
the reduction in the sample size within each cluster to
less than half the total sample size, it is not surprising
that only one CpG achieves a genomewide significant
correlation with maternal age. Nevertheless, for the pur-
poses of evaluating the possibility of confounding
between maternal age and race, it is more relevant to
compare the trends between the genetically distinct
clusters of newborns. A correlation analysis of the
Spearman rho statistics between the two clusters is
highly significant (rho = 0.39, p < 10-14; using newborns
declared as only one race, N = 162, rho = 0.41, p < 10-
14), indicating that similar trends exist in both groups.
Restricting attention to rho statistics with a magnitude ≥
0.2 (roughly p ≤ 0.1), indicating a relatively strong trend,
there are 2,584 CpGs which achieve this level in both
groups. Of these, only 175 (7%) have rho statistics with
opposite signs, meaning strong trends in the opposite
directions. Overall, these results indicate that correla-
tions between maternal age and newborn CpG methyla-
tion are similar in groups defined by race or genetic
principal components and that confounding by racial
differences in DNA methylation levels or average mater-
nal age is not a major influence.
Although overall racial differences in DNA methyla-
tion levels do not appear to be confounding our obser-
vation of correlations between maternal age and
newborn DNA methylation, a more subtle confounding
could arise from the presence of sequence polymorph-
isms, particularly SNPs, within the regions targeted by
probes on the Humanmethylation27 array whose allele
frequencies differ between the races and which could
affect the hybridization of DNA to the array. Using the
UCSC Genome Browser http://genome.ucsc.edu we
examined a window of 50 nucleotides upstream and
downstream of each of the 144 genomewide significant
CpGs correlated with maternal age. Of the 144 signifi-
cant CpGs, 60 are within 50 nucleotides of at least one
polymorphism listed within dbSNP http://www.ncbi.nlm.
nih.gov/SNP/. Therefore, up to 42% of our genomewide
significant correlations with maternal age could be arti-
facts caused by known polymorphisms in the human
genome. Given that we used a rather liberal criterion for
defining potential sequence effects and did not directly
determine if the probes on the Illumina arrays physically
overlap these polymorphisms, the number of potential
artifacts due to altered hybridization is undoubtedly
lower than 42%.
Figure 3 Scatterplot of newborns along the first and second
principal components calculated from genome-wide single
nucleotide polymorphism data. Maternally-declared Caucasian
newborns are represented by circles and African-American
newborns by X’s.
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Functional Clusters and Disease Processes
Among the 1,494 CpGs correlated with maternal age at
a false discovery rate of 6.69 × 10-4 (see Methods), 1,423
genes are represented, including 12 imprinted loci
(KCNQ1, PRIM2, PLAGL1, GRB10, H19, IGF2,
CDKN1C, WT1, TCEB3C, PEG3, GNAS, ZNF331). Can-
cer was the single disease category (1.43-fold enrich-
ment, p = 3.42 × 10-5) significantly over-represented
based on the presence of 96 genes associated with its
etiology or progression (Additional File 3, Table S3).
Clustering of those 1,423 genes based on ontology
resulted in 14 significantly over-represented functional
categories (Table 2; Additional File 4, Table S4). The
principal functions represented by these categories were
mesodermal development, metabolic regulation, nucleo-
cytoplasmic transport, and transcriptional regulation.
Relationship between maternal age and newborn DNA
methylation in blood cell type signature genes
Of 852 loci with official gene symbols whose expression
levels are signatures of blood cell types [38], we found
658 that were assayed by the Humanmethylation27
array. These 658 genes are represented by 1,273 CpG
probes on the Illumina array (Additional File 5, Table
S5). The first principal component based on the methy-
lation levels of these probes among the 168 newborns
explained 97.9% of the variation. Both visually and based
on Spearman correlation (rho = 0.07, p = 0.34), there
was no apparent relationship between the principal
component representing combined blood cell signature
gene methylation and maternal age. Of those 1,273 indi-
vidual probes, 7 (0.55%; within genes C19orf6, GM2A,
SEPX1, RPL27, CTSZ, PGAM1, PLXDC1) were among
those significantly correlated with maternal age. Given
that this proportion is nearly identical to the proportion
of CpG probes genome-wide showing significant corre-
lation with maternal age (0.52%; P(7/1,273 ≥ 0.52%) =
0.49, binomial test), blood cell type signature genes do
not appear to be enriched among the significant CpG
probes, thereby providing indirect evidence against
changes in umbilical blood cell composition with mater-
nal age.
Discussion
To the extent of our knowledge, this is the first demon-
stration of a trans-generational effect of parental, pri-
marily maternal, age on the levels of DNA methylation
in the next generation at birth. Clusters of CpG dinu-
cleotides, or CpG islands, are disproportionately located
in the upstream, regulatory regions of genes and typi-
cally exhibit lower levels of methylation than do non-
island CpGs. In this sense the trend we observed
towards decreased methylation of newborn CpG islands
with increasing parental age represents an accentuation
of a normal pattern of DNA methylation. In this con-
text, the question becomes whether these changes are
related to disease or other phenotypic outcomes in the
offspring. As was noted earlier, the children of older
parents have increased risks of type 1 diabetes, neurode-
velopmental disorders, and cancer. Therefore, it is note-
worthy that cancer was the disease category
over-represented by genes whose methylation strongly
correlated with maternal age. A survey of Online Men-
delian Inheritance in Man (OMIM) [39] for the 142
genes that achieved genome-wide significance with age
in our sample reveals several genes with known func-
tional or molecular associations with cancer, obesity,
and diabetes (Table 3). This is suggestive of a possible
role of maternal age-associated shifts in newborn methy-
lation in the increased risks of these outcomes. However,
Table 2 Functional clusters of 1,493 CpGs (1,423 genes) with strongest correlations between levels of methylation and
maternal age according to DAVID
Terms # Genes Minimum DAVID p Value Enrichment Score
Mesenchymal cell development/differentiation 11 0.003 2.53
Formation of mesoderm/primary germ layer 9 0.003 2.34
Neurological regulation 19 0.008 1.83
Regulation of glucose/carbohydrate metabolic process 8 0.01 1.83
Unsaturated fatty/icosanoid metabolism/biosynthesis 8 0.005 1.71
Negative regulation nucleocytoplasmic protein/transcription factor transport 5 0.006 1.70
Regulation nucleocytoplasmic protein/transcription factor transport 10 0.01 1.60
Limb morphogenesis 14 0.02 1.57
Phosphopantetheine-binding, acyl carrier activity 3 0.01 1.53
MADS-box 3 0.04 1.40
Helix-loop-helix 14 0.03 1.37
Positive regulation of glucose/carbohydrate metabolism 5 0.04 1.33
Negative regulation of phosphorylation 8 0.04 1.33
Regulation of transmembrane transport 6 0.03 1.32
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it must be emphasized that the associations listed in
OMIM are almost exclusively due to genetic defects in
these genes, while hypomethylation of CpGs, particularly
in CpG islands, is expected to result in increased expres-
sion of these genes, rather than repression.
According to DAVID [40,41], there were 14 func-
tions enriched among the 1,493 genes with the stron-
gest correlations between maternal age and newborn
DNA methylation. The category with the second great-
est enrichment was mesodermal development, and this
is not surprising given that white blood cells originate
from the mesodermal layer. The third greatest enrich-
ment was for functions related to neurological regula-
tion, including strong candidate genes for psychiatric
disorders such as SLC6A1, GNAI3, PTGS2, and
CTNND2. Given the association between increasing
parental age and schizophrenia, bipolar disorder and
autism in offspring, studies of shifts in the methylation
of these genes in offspring of older parents are war-
ranted. Similarly, the risk of diabetes appears to be ele-
vated in the children of older parents, and functions
related to glucose and carbohydrate metabolism are
enriched among the genes whose methylation is corre-
lated with maternal age, including such candidate
genes for obesity and diabetes as IRS1, IRS2, DUSP12,
DYRK2, and ARNT.
Multiple reports have documented significant changes
in DNA methylation patterns with age in adults, both as
a genome-wide average and at specific nucleotide sites.
The question arises as to whether these adult patterns
mirror those we observed in newborns, which would
imply that the same processes are operating both in
adult somatic tissues and in either gametogenesis or
embryonic development. Of the 589 CpGs with signifi-
cant correlation with age in adults discovered by
Teschendorff et al. [13], only one (in PLAT) achieved
genome-wide significance among our newborns. Simi-
larly, of the 131 CpGs studied by Rakyan et al. [11]
whose methylation levels in adults were positively corre-
lated with age and were highly replicable, only one (in
RFXDC1) was observed by us to have a trans-genera-
tional effect. By contrast, 30 genes overlapped between
Rakyan et al. and Teschendorff et al. Among the 288
CpGs studied by Boks et al. [10], 90 loci located in 69
genes were associated with adult age at p ≤ 0.05. CpGs
in two of those genes (GAS7 and RYK) were also signifi-
cant in our cohort. Likewise, of the 106 CpGs in 73
genes found to be significantly related to age in blood
by Christensen et al. [9], only one gene (PLAT) was
among our significant results. With the exception of a
very small number of genes, these comparisons indicate
that the processes resulting in age-related trends in
Table 3 Diseases and functions reported to be associated with genes exhibiting a significant correlation between
methylation and maternal age
Gene Phenotype/Function OMIM Reference




TUBB2A Polymicrogyria, asymmetric 610031
RAD51 Breast cancer, familial 114480
C19orf6 Ovarian, breast, pancreatic and colorectal cancer expression 611011
RAD54L Adenocarcinoma, colonic, somatic; Lymphoma, non-Hodgkin; Breast cancer, invasive ductal 603615
ACADS SCAD deficiency 201470
GM2A Gangliosidase, AB variant 272750
STAT5B Growth hormone insensitivity with immunodeficiency 245590
RET Multiple endocrine neoplasia, type IIA; Hirschprung disease; Central hypoventilation syndrome; renal
agenesis
142623 209880 191830
ZFYVE26 Spastic paraplegia 15, autosomal recessive 270700
RBBP9 Transformation to cancer 602908
MRPS22 Combined oxidative phosphorylation deficiency 5 611719
MYC Burkitt lymphoma 113970
RFXDC1 Diabetes, neonatal, with pancreatic hypoplasia, intestinal atresia and gallbladder aplasia or hypoplasia 601346
MYST1 Histone acetyltransferase 609912
RASSF1 Tumor suppressor 605082
ZBT16 Skeletal defects, genital hypoplasia, and mental retardation 612447
ACTN4 Focal glomerulosclerosis 1 603278
NR0B2 Obesity, mild, early-onset 604630
ALX4 Parietal foramina 2 609597
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DNA methylation in adult somatic tissues and in new-
born somatic tissues may be independent.
There are two most likely possibilities to explain the
differences. First, the patterns of change in methylation
in oocytes and/or spermatocytes with respect to age are
different than in somatic tissue and these are reflected
in shifted patterns in the newborn. This explanation can
be tested by comparison of methylation patterns in
somatic tissues and gametes in the same individuals
with respect to age. Second, the mechanisms of estab-
lishment and/or maintenance of DNA methylation in
the developing fetus could be responsive to parental age,
but in a manner different than in the adult somatic tis-
sues. This hypothesis cannot be tested by epidemiologi-
cal methods but instead requires detailed molecular
biological examination.
It is well-established that DNA methylation of
imprinted genes is established in a parent of origin man-
ner during development of the germ line and gameto-
genesis [42], while methylation of other loci is thought
to be re-established after a nearly global demethylation
subsequent to fertilization and uterine implantation.
Given the stringency with which DNA methylation is
thought to be maintained at imprinted loci, it is some-
what surprising that DNA methylation at 2 imprinted
loci exhibited genomewide-wide significant correlations
with maternal age and a total of 12 met the less strin-
gent q value threshold of 6.69 × 10-4. However, there is
evidence that the methylation patterns present in the
parents are not totally erased and reset during gameto-
genesis and fertilization at a proportion of loci, includ-
ing both imprinted and non-imprinted genes. Borgel
et al. [43] identified a set of 215 genes that are methy-
lated in the mouse very early in embryonic development
and well before implantation. Of the few loci tested, all
were methylated in gametes, with some shifts in those
patterns being observed in preimplantation embryos.
Although these observations do not address the issue of
whether age-related changes in DNA methylation pre-
viously found in somatic tissues are mechanistically
related to the trends we have tentatively identified to be
related to maternal age, they do indicate a definite
potential for trans-generational inheritance of DNA
methylation patterns
A proportion of the age-related changes in DNA
methylation observed in adult cohorts has been attribu-
ted to changes in blood cell composition as an indivi-
dual ages. Therefore, the possibility exists that the
changes in patterns of newborn DNA methylation
which were observed may be at least partly due to
changes in umbilical cord blood cell composition during
pregnancy. However, we found no significant relation-
ship between gestational age and CpG methylation in
newborn cord blood, and therefore the gestational age
of the fetus is an unlikely explanation for these differ-
ences. There is no obvious mechanism by which the
mother’s (or father’s) age would shift cord blood cell
composition. We did not directly assess the relative pro-
portion of cell types in our cord blood samples. In our
examination of the methylation patterns among genes
whose expression levels are characteristic of major
blood cell types, we found no obvious relationship to
maternal age or over-representation of these genes
among the significant results. Although this does not
disprove that changes in blood cell composition explain
all or part of our results, these findings are not consis-
tent with substantial differences in blood cell composi-
tion or the regulation via methylation of the genes that
are signatures of major cell subtypes.
There is the obvious question as to whether the
changes in DNA methylation patterns we observed in
umbilical cord blood are representative of patterns in
other tissues of the newborn. It is widely accepted
that diverging patterns of methylation at individual
loci are a key aspect of cellular differentiation during
development, and as a consequence levels of methyla-
tion at a subset of loci between two different tissue
types will differ. However, there is also evidence of
similarities in patterns of methylation across tissue
types. For example, methylation levels of IGF2 and
ER-a in peripheral blood mirror those of colon tissue
[44,45]. Additionally, comparisons among multiple tis-
sues from multiple autopsy subjects reveal individual-
specific and locus-specific patterns of DNA methyla-
tion but a high degree of similarity among tissues
within the same individual [46]. Likewise, within an
individual there is similarity in methylation patterns
between blood and buccal cells [47]. Given that these
similarities are shared among tissues with different
embryonic origins, this suggests that the similarities
are established early in development and are fairly
persistent throughout life.
Conclusions
At a subset of loci, levels of DNA methylation in umbili-
cal cord blood are strongly correlated with maternal,
and to a lesser extent paternal, age. This correlation is
predominantly negative and disproportionately occurs
within CpG islands. Genes associated with oncogenesis
and cancer progression are significantly over-repre-
sented among the genes correlated with maternal age,
and this suggests a link to known increased risks of can-
cer among the children of older parents. Similarly, gene
functions related to neurodevelopment and neuroregula-
tion are over-represented among the strongly correlated
genes, and this may have relevance to the increasing
risk of neurodevelopmental and psychiatric disorders in
offspring as parental ages increase.
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Methods
Participants and Samples
From a longitudinal study (Conditions Affecting Neuro-
cognitive Development and Learning in Early Child-
hood; CANDLE) of child development from the second
trimester of a singleton pregnancy until age 3 in Mem-
phis TN, the first 168 newborns were chosen for which
blood samples were available for both the mother and
her newborn and for which there were no infectious or
chronic illnesses in the mothers and no pregnancy com-
plications. Newborn blood was collected from the umbi-
lical cord at delivery. After centrifugation of whole
blood, the buffy coat was collected and frozen. Subse-
quently, Wizard genomic DNA purification reagents
(Promega Corp.) were used for DNA extraction. All
demographic and phenotypic data on the mothers and
newborns were abstracted from clinical records. Paternal
ages were reported by the mothers via mail question-
naires and phone calls during the months after delivery
of the newborn. This research was approved by the
Institutional Review Board of the University of Tennes-
see Health Science Center, and informed consent was
obtained from all mothers.
Genome-wide measurement of DNA methylation levels
Bisulfite conversion of 750 ng of genomic DNA was per-
formed using EZ DNA Methylation reagents (Zymo
Research). Samples were then processed according to
manufacturer’s specifications and hybridized and
scanned on the Humanmethylation27 BeadChip (Illu-
mina Inc.) in batches of 24 samples using the Illumina
BeadStation. The Humanmethylation27 BeadChip bears
probes for 27,578 specific CpG dinucleotides assigned to
14,495 loci. The level of methylation of each CpG is
represented by a beta value, which is calculated as the
level of the fluorescence for the probe specific for 5-
methylcytosine divided by the fluorescence from the
probes for both the methylated and unmethylated C at
that position. Consequently, the beta values span the
bounded range 0 - 1. The data has been submitted to
the Gene Expression omnibus data base with accession
number GSE27317.
Subsequent to statistical analyses, three CpGs with dif-
fering levels of methylation from the Illumina data that
also were among the top-ranked p values were chosen
for validation by pyrosequencing. This work was per-
formed by a commercial service (EpigenDx, Worcester,
MA). Upon receipt of 92 DNA samples, EpigenDx per-
formed the bisulfite conversion, designed the assays, and
performed pyrosequencing with the inclusion of high
and low methylation controls. For all three assays,
results from control DNAs indicated complete bisulfite
conversion.
Correlation between newborn CpG methylation and both
parental and newborn characteristics
Raw output files from array hybridization experiments
were processed using GenomeStudio software (Illumina
Inc.). This software reports detection p values for each
CpG interrogated by the array, which are an indication
of the ability to distinguish the target sequence from
background. Beta values representing the proportion of
methylation at each site and the corresponding detec-
tion p values were imported into Microsoft SQL Server
2005, where filtering of the data values was performed
before statistical analyses. For each newborn, probes
with detection p values ≥ 10-3 were dropped from that
individual. Additionally, any probe with a median detec-
tion p value ≥10-6 across newborns was dropped from
all individuals.
Statistical analyses were performed using SPSS version
18 (SPSS Inc.) and Stata 10 (Stata Corp.). Several vari-
ables related to the mothers, fathers and newborns
could possibly be related to DNA methylation levels at
individual CpG sites. Therefore, we performed statistical
analyses to examine the association between each of
these variables and the level of methylation at each
CpG. Because the distribution of DNA methylation at
many sites is not normal, we performed nonparametric
analyses. Specifically, for continuous variables (maternal
age, paternal age, parity, maternal body mass index,
gestational age, birth weight) we performed Spearman
rank correlation, and for binary variables (maternal
smoking during pregnancy, newborn gender) we per-
formed Wilcoxon rank sum analysis. Maternal BMI was
based on the mother’s height and her report of prepreg-
nancy weight at the time of recruitment in the early sec-
ond trimester of pregnancy. Prior to analysis, regression
of birth weight on gestational age, gender, maternal pre-
pregnancy BMI and race was performed, and the resi-
duals used for correlation. A Bonferroni-corrected
genome-wide threshold for statistical significance of
1.81 × 10-6 for the relationship between each variable
and the levels of DNA methylation at each CpG was
employed based on the 27,576 tests performed for each
variable.
Systematic differences between the two races in DNA
methylation levels or maternal age are potential con-
founders in the analyses of correlations between mater-
nal age and newborn DNA methylation. To address the
influence of these potential confounders, we used inde-
pendent genome-wide SNP data collected on a subset
(63 African-American, 68 Caucasian) of the participants
using the Affymetrix (Santa Clara CA, USA) Genome-
wide SNP 5.0 and 6.0 arrays. Samples were processed
according to Affymetrix’s protocol and genotypes were
called using the BRLMM (5.0 array) and Birdseed (6.0
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array) algorithms with default parameters within the
Affymetrix Genotyping Console v4.0 application. Based
on the genome-wide patterns of SNP genotypes, load-
ings on the first two principal components were calcu-
lated using the SNP and Variation Suite module of the
GoldenHelix v7 software (Golden Helix Inc., Bozeman
MT, USA). Based on plots of the loadings on the first
two principal components, two genetically distinct
groups of participants were identified. Within these
comparatively more genetically homogeneous groups,
correlations between maternal age and newborn DNA
methylation were performed for comparison to analyses
across all individuals to determine if population sub-
structuring of genetic variation confounded the main
analyses of parental age effects on DNA methylation
patterns.
Functional and disease clustering of significant genes
The Database for Annotation, Visualization, and Inte-
grated Discovery [DAVID, 41, 48] was used to group
genes according to functional category and to identify
disease processes highly represented among the loci
most strongly associated with maternal age. The Bonfer-
roni correction we used to assign significance to loci is
likely to be too stringent and to exclude many loci truly
correlated with maternal age. Therefore, for the purpose
of identifying potentially affected physiological functions
and disease processes, we based our selection of loci on
false discovery rate q values, or the expected proportion
of loci at that threshold of significance that are likely to
be false positives. A visual inspection of plots of the
number of tests declared significant versus the q value
produced by the QVALUE program [49,50] illustrated
that the relationship sharply changed beyond a q value
of about 0.001. To be conservative, we used a q value
threshold of 6.69 × 10-4 (corresponding to a p value of
9.55 × 10-5), which results in an expectation that
approximately one CpG out of the 1,493 declared signif-
icant is a false positive. These 1,493 CpGs belonged to
1,423 different genes. For identification of functional
clusters, we used the highest classification stringency
and restricted attention to enrichment scores ≥ 1.3,
roughly corresponding to a p value of 0.05 (10-1.3). As
the background reference set of genes, we used the non-
redundant list of genes represented on the Human-
methylation27 array as identified by the Entrez gene ID
numbers provided by Illumina in their annotation of the
array. The identification of imprinted loci was based on
the online imprinted gene and parent-of-origin effect
database http://igc.otago.ac.nz/home.html [51]. Using
liberal criteria, we considered 59 loci with known or
polymorphic imprinting patterns or provisional evidence
of imprinting.
Univariate and multivariate analyses of genes whose
expression or DNA methylation are characteristic of
blood cell types
Previous observations of a relationship between adult
age and changes in DNA methylation have sometimes
been attributed to changes in blood cell composition as
an individual ages. Palmer et al. [38] identified genes
whose expression is characteristic of B-cells, T-cell sub-
types, granulocytes and lymphocytes. Although they did
not directly determine the blood cell type composition
of their ovarian cancer case-control cohort, Teschen-
dorff et al. [52] used Palmer et al.’s [38] blood cell sub-
type-specific expression signatures and the same
methylation array used in our study to infer that age-
related changes in DNA methylation in their cohort
could principally be explained by changes in blood cell
composition based on the over-representation of genes
whose expression levels are signatures of blood cell sub-
types. To indirectly address the possibility that the pat-
terns we observe could be due to maternal age-related
changes in the relative proportions of newborn cord
blood cell types, we also used the data of Palmer et al.
[38].
Based on gene symbols, we identified the overlap
between the signature genes reported by Palmer et al.
and the genes targeted by the Illumina methylation
array. Using all of the probes among these genes, we
performed principal components analysis. To visually
examine the relationship, we plotted the first principal
component versus maternal age. Additionally, we calcu-
lated the Spearman rank correlation between maternal
age and the first principal component. The principal
component analysis summarizes the variability due to all
of the probes in the blood cell type signature genes.
However, any relationship between maternal age and
changes in cord blood cell type composition may be due
to a subset of genes or probes. Therefore, we also exam-
ined the rank correlation between maternal age and
each probe in signature genes.
Additional material
Additional file 1: Table S1. Summary of statistical results for each CpG,
including select annotation from Illumina.
Additional file 2: Table S2. List of the 144 CpGs with genome-wide
significant correlation between newborn methylation and maternal age
and the CpG with next smallest p value. Whether the 1st and 2nd CpG
exhibit correlation with maternal age in the same direction and whether
the 2nd CpG is significant at a nominal p value of 0.05 is indicated.
Additional file 3: Table S3. Output from DAVID analysis of disease
clustering among the 1,423 genes whose level of methylation was
correlated with maternal age at a q value of 6.69 × 10-4, corresponding
to an expectation of one false positive and p = 9.55 × 10-5.
Additional file 4: Table S4. Output of functional clustering of 1,423
genes whose level of newborn methylation was correlated with maternal
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age at a q value of 6.69 × 10-4, corresponding to an expectation of one
false positive and p = 9.55 × 10-5 by DAVID.
Additional file 5: Table S5. List of 1,273 Humanmethylation27 array
probes and 658 genes overlapping with blood cell type signature genes
identified by Palmer et al. (2006. Cell-type specific gene expression
profiles of leukocytes in human peripheral blood. BMC Genomics 7, 115).
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